Columbia Laboratories, Inc. (CBRX)

[abc2438]

I hear ya. Hopefully we have a dramatic increase in the next couple years.

[mr_sano]

Been dead wrong on every target i had in my mind here so sorry I can,t even venture a guess. I own some at pre r/s at $10!

[abc2438]

You have been in this stock for a long time. Do you mind if I ask what your price target is?

[mr_sano]

Well that's interesting...it does appear company looking to re-position out of its horrifying past. Lets hope they can make a go of it. Technically or fundamentally. I don't care which way gets it there.

[stocktrademan]

technical analysis doesn't care about a name change, it only looks at the present chart, which at this time looks excellent with 40%+ upside

[mr_sano]

Name change?!? I guess not a bad idea.given the historically bad performance Columbia has had.

[stocktrademan]

$CBRX recent news/filings

bullish
bouncing and breaking out over moving averages

## source: finance.yahoo.com

Fri, 03 Apr 2015 13:02:16 GMT ~ COLUMBIA LABORATORIES INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financ


read full: http://biz.yahoo.com/e/150403/cbrx8-k.html
*********************************************************

Thu, 02 Apr 2015 11:50:44 GMT ~ Columbia Laboratories, Inc. to Become Juniper Pharmaceuticals, Inc.

[at noodls] - BOSTON , April 2, 2015 /PRNewswire/ -- Columbia Laboratories, Inc. (Nasdaq: CBRX) (the "Company"), today announced that it will adopt Juniper Pharmaceuticals, Inc. as its new corporate brand. ...

read full: http://www.noodls.com/view/1E8FB761EC0C97029667C2EA36C2DBD869E27C90
*********************************************************

Thu, 02 Apr 2015 11:30:00 GMT ~ Columbia Laboratories, Inc. to Become Juniper Pharmaceuticals, Inc.

[PR Newswire] - BOSTON, April 2, 2015 /PRNewswire/ -- Columbia Laboratories, Inc. (CBRX) (the "Company"), today announced that it will adopt Juniper Pharmaceuticals, Inc. as its new corporate brand. The name change will become effective Friday, April 10, 2015, and the Company's common stock will begin trading on the Nasdaq Stock Exchange under the new ticker symbol — "JNP" — on Monday, April 13, 2015. The Company will also unveil its new logo and launch its new website, www.juniperpharma.com, on April 13, 2015. "Adopting the Juniper Pharmaceuticals brand marks the next step in the Company's return to developing specialty products in women's health.

read full: http://finance.yahoo.com/news/columbia-laboratories-inc-become-juniper-113000499.html
*********************************************************

Wed, 01 Apr 2015 20:17:06 GMT ~ COLUMBIA LABORATORIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Ex


read full: http://biz.yahoo.com/e/150401/cbrx8-k.html
*********************************************************

Mon, 30 Mar 2015 12:04:08 GMT ~ Columbia Laboratories Acquires Exclusive Worldwide License to a Novel Segmented Intra-vaginal Ring Delivery Technology

[at noodls] - BOSTON , March 30, 2015 /PRNewswire/ -- Columbia Laboratories, Inc. (Nasdaq: CBRX) ("Columbia" or "the Company"), a specialty pharmaceutical company focused on the development of therapeutics ...

read full: http://www.noodls.com/view/47E6C43013B9F0B15C7E92E0ED5777119C8DC9A7
*********************************************************

$CBRX charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$CBRX company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/CBRX/company-info
Ticker: $CBRX
OTC Market Place: Not Available
CIK code: 0000821995
Company name: Columbia Laboratories, Inc.
Company website: http://www.columbialabs.com
Incorporated In: DE, USA

$CBRX share structure

## source: otcmarkets.com

Market Value: $67,236,630 a/o Apr 07, 2015
Shares Outstanding: 10,775,101 a/o Mar 03, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available

$CBRX extra dd links

Company name: Columbia Laboratories, Inc.
Company website: http://www.columbialabs.com

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/CBRX/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/CBRX/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=CBRX+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=CBRX+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=CBRX+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/CBRX/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/CBRX/news - http://finance.yahoo.com/q/h?s=CBRX+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/CBRX/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/CBRX/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/CBRX/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/CBRX/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/CBRX/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/CBRX/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/CBRX/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/CBRX/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=CBRX+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/CBRX
DTCC (dtcc.com): http://search2.dtcc.com/?q=Columbia+Laboratories%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Columbia+Laboratories%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Columbia+Laboratories%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.columbialabs.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.columbialabs.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.columbialabs.com

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/CBRX/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/CBRX
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/CBRX/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/CBRX/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/CBRX/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000821995&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/CBRX/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/CBRX/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/CBRX/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/CBRX/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=CBRX&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=CBRX
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/CBRX/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=CBRX+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=CBRX+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=CBRX
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=CBRX
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=CBRX+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/CBRX/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=CBRX+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/CBRX.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=CBRX
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/CBRX/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/CBRX/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/CBRX/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/CBRX/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/CBRX
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/CBRX
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/CBRX:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=CBRX
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=CBRX



$CBRX DD Notes ~ http://www.ddnotesmaker.com/CBRX

[mr_sano]

I don't honestly know how this effects the company. Is this a delivery system that can licensed out for various drugs? Segmented ring...it just feel like the company fragmented.

[abc2438]

I am having a hard time understanding the magnitude of the last pr. Maybe that is part of the issue. You did always say, this stock is snake bit.

[mr_sano]

Classic sell the news

[mr_sano]

No kidding...very little communication on part of ir. I emailed them awhile back and got the standard pat answer.

[abc2438]

Folks are not impressed with Molecular's performance to date...

[mr_sano]

Back to the pain cycle!

[abc2438]

Well said.

[mr_sano]

I've been burned so many times with Cbrx I don't know what to expect. I've owned it for 25 years. Every time I though it was poised for explosive growth I got smoked. I guess I am pandering to my contra side. Anyway it's good to see some life albeit long overdue. I question the direction of the company though. Management always seems to eat steak while the loyal get fed by scraps.

[abc2438]

I take it you aren't impressed with the Lidocaine potential?

[mr_sano]

Yep still holding have no idea why this has recovered a bit.

[abc2438]

Finally some good news with this stock. Curious how the earning will relate to the upcoming conference, if at all. You still in this Sano?

Chart looks a bit toppy, but at least there is a product up for approval. Curious, what the second product mentioned in the last conference will be this year. At least there is potential for upside to go along with the NOLs and solid financials. Cautiously optimistic about this year.

[mr_sano]

Finally a little life!

[mr_sano]

New CFO...this guy didn't last too long. Another golden parachute!

[mr_sano]

21 shares traded so far!! Wow this is truly dead money.

[mr_sano]

Went through support like a hot knife through butter!

[mr_sano]

Say goodbye to 6's!

[mr_sano]

Another crap q and more excuses. This company is toast.

[mr_sano]

Attention Cbrx management when do expect to earn your salaries and cushy perks by returning value to your shareholders? This company desperately needs new leadership. Rookie bio pharma execs taking down big dough while investors loose every year.

[mr_sano]

How'd that strategy working mr CEO ?

[mr_sano]

Man this company has died and gone to heaven. Sub. 6's soon . Thank you management for fragmenting the company!

[mr_sano]

Cbrx flying stealth mode 20 k in volume nobody's cares anymore. Kudos for condella stepping up but 65k is scratch money with his comp package. Too little too late!

[abc2438]

http://www.insidercow.com

FC bought 10,000 shares on Monday.

[mr_sano]

.01 a share is dismal.

[mr_sano]

Time for management to take a pay cut.

[mr_sano]

Proxy shows whos making money. INsiders. FC nice big checks and options. Boy these guys really treat themselves well don;t they?

[abc2438]

Chinese water torture!

[mr_sano]

Lol this company is pure torture to follow!

[abc2438]

Yeah, you deserve a nice run!

[mr_sano]

Hopefully something pushes this higher rather than gimmicks. I have had this stock for 26 years!!

[abc2438]

A few pretty big buys disguised in the low volume in the last few days.

[abc2438]

Thanks for your insight. We'll see if anything comes of this supposed IP.

[mr_sano]

Yeah we are snakebit. I wasn't too impressed with the the CC although I only read the the transcript. As far as the buyback I 'm not a fan. If we had great managment they will deploy the assets accordingly to get us a return. The BB may work in the short term but its cash out the door and if I was the CFO I would have hard time rationalizing it. This likely response to shareholder letter made public last month. It could be they got railroaded into it.

Earnings were nothing to write home about although I'll take anything that supports the PE. I didn't see the immediate synergy of the molecule deal...hopefully later but seems to be the company is now based offshore which is another negative for me.

[abc2438]

I thought we would be testing the mid to upper 7's today. Can't believe less than 100k shares were traded today. Any thoughts?

[mr_sano]

lol why is this not up 5%??? The horror!

[abc2438]

Do they need to announce they are getting into the marijuana industry in order to get a significant boost in SP?

[abc2438]

http://ih.advfn.com/p.php?pid=nmona&article=61362462&symbol=CBRX

Nice news. Let's see if this gets things rolling.

[mr_sano]

Restated earnings ??? ok can't they get the books done right. Man this company is going to get cooked in the cc. I hope they open it up to the common holder.

[mr_sano]

Need some catalyst here

[abc2438]

Haha. Yep.

[mr_sano]

You would think that with their pay grade they would have that skill. Not that I am surprised .

[abc2438]

I did. A salesperson he is not. He did mention he would be updating the market in regards to progress with Molecular, but didn't say when.

[mr_sano]

Apparently what ever they presented didn't set anything on fire. Anybody catch the presentation?

[starbuxsux]

Nice break to the upside